Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Canadian Pacific Kansas City
CP
|
$254M |
| 2 |
Cadence Bank
CADE
|
$211M |
| 3 |
Realty Income
O
|
$152M |
| 4 |
Verizon
VZ
|
$148M |
| 5 |
Amazon
AMZN
|
$130M |
Top Sells
| 1 |
KSU
Kansas City Southern
KSU
|
$347M |
| 2 |
Zurn Elkay Water Solutions
ZWS
|
$330M |
| 3 |
UFS
DOMTAR CORPORATION (New)
UFS
|
$197M |
| 4 |
Oracle
ORCL
|
$166M |
| 5 |
Federal Realty Investment Trust
FRT
|
$148M |
Sector Composition
| 1 | Technology | 17.41% |
| 2 | Financials | 17.04% |
| 3 | Industrials | 12.6% |
| 4 | Consumer Discretionary | 11.28% |
| 5 | Healthcare | 11.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BIOC
3376
DELISTED
Biocept, Inc.
BIOC
| $159K | ﹤0.01% |
+1,468
| New | +$159K |
|
3377
Actinium Pharmaceuticals
ATNM
$49.3M
| $157K | ﹤0.01% |
26,109
+15,030
| +136% | +$90.4K |
|
3378
CVD Equipment Corp
CVV
$19.1M
| $155K | ﹤0.01% |
37,633
+23
| +0.1% | +$95 |
|
3379
ImmuCell
ICCC
$57.3M
| $155K | ﹤0.01% |
19,393
-1,121
| -5% | -$8.96K |
|
3380
WidePoint Corp
WYY
$49.2M
| $154K | ﹤0.01% |
39,083
-4,649
| -11% | -$18.3K |
|
|
ICD
3381
DELISTED
Independence Contract Drilling, Inc.
ICD
| $153K | ﹤0.01% |
50,840
+24,762
| +95% | +$74.5K |
|
3382
Karyopharm Therapeutics
KPTI
$57.2M
| $152K | ﹤0.01% |
1,571
| – | – |
|
3383
X4 Pharmaceuticals
XFOR
$78.6M
| $152K | ﹤0.01% |
2,206
-244
| -10% | -$16.8K |
|
|
IMGN
3384
DELISTED
Immunogen Inc
IMGN
| $152K | ﹤0.01% |
20,517
-102,709
| -83% | -$761K |
|
3385
Cabaletta Bio
CABA
$155M
| $151K | ﹤0.01% |
+39,942
| New | +$151K |
|
|
AUTO
3386
DELISTED
AutoWeb, Inc. Common Stock
AUTO
| $151K | ﹤0.01% |
44,363
| – | – |
|
3387
Wave Life Sciences
WVE
$1.32B
| $150K | ﹤0.01% |
47,889
-5,159
| -10% | -$16.2K |
|
3388
Gevo
GEVO
$404M
| $148K | ﹤0.01% |
34,646
| – | – |
|
3389
MediciNova
MNOV
$63.3M
| $147K | ﹤0.01% |
54,855
+323
| +0.6% | +$866 |
|
3390
Passage Bio
PASG
$22.8M
| $147K | ﹤0.01% |
1,158
+428
| +59% | +$54.3K |
|
3391
Santander
BSBR
$40.6B
| $146K | ﹤0.01% |
27,100
-1,192
| -4% | -$6.42K |
|
3392
One Stop Systems
OSS
$126M
| $146K | ﹤0.01% |
29,400
-531
| -2% | -$2.64K |
|
|
LUMO
3393
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $144K | ﹤0.01% |
20,731
-222
| -1% | -$1.54K |
|
|
FNCB
3394
DELISTED
FNCB Bancorp Inc. Common Stock
FNCB
| $144K | ﹤0.01% |
15,799
+5,203
| +49% | +$47.4K |
|
3395
Neurogene
NGNE
$285M
| $142K | ﹤0.01% |
1,472
+315
| +27% | +$30.4K |
|
|
CIH
3396
DELISTED
China Index Holdings Limited American Depository Shares
CIH
| $142K | ﹤0.01% |
146,713
+34
| +0% | +$33 |
|
3397
Eletrobras Preferred Shares
EBR.B
$20B
| $141K | ﹤0.01% |
24,031
| – | – |
|
|
XIN
3398
DELISTED
Xinyuan Real Estate
XIN
| $141K | ﹤0.01% |
22,472
-74,973
| -77% | -$470K |
|
3399
Jerash Holdings
JRSH
$43.6M
| $137K | ﹤0.01% |
21,111
+3,812
| +22% | +$24.7K |
|
|
GOGL
3400
DELISTED
Golden Ocean Group
GOGL
| $135K | ﹤0.01% |
14,527
| – | – |
|